DavidMarshallGuttmannMD

PubMed

• 18 citations
  Prophylactic Radiation Therapy Versus Standard of Care for Patients With High-Risk Asymptomatic Bone Metastases: A Multicenter, Randomized Phase II Clinical Trial.
  Erin F Gillespie, Joanna C Yang, Noah J Mathis, Catherine B Marine, Charlie White
  Journal of Clinical Oncology. 2024-01-01
• 49 citations
  National disparities in treatment package time for resected locally advanced head and neck cancer and impact on overall survival
  David M. Guttmann, Julie Kobie, Surbhi Grover, Alexander Lin, John N. Lukens
  Head & Neck. 2018-06-01
• 35 citations
  Improved Overall Survival with Aggressive Primary Tumor Radiotherapy for Patients with Metastatic Esophageal Cancer
  David M. Guttmann, Nandita Mitra, Justin E. Bekelman, James M. Metz, John P. Plastaras
  Journal of Thoracic Oncology. 2017-07-01

Abstracts/Posters

• Radiation Dermatitis and Modality Predict Wound Complications in Patients with Soft Tissue Sarcoma.
  LeBrun DG, Guttmann DM, Levin WP, Kovach SJ, Weber KL, American Academy of Orthopedic Surgeons Annual Meeting, 1/1/2017
• Head and Neck Cancer Survival Outcome Prediction Based on NRG Oncology RTOG 0522 with Random Forests and Random Survival Forests.
  Huang M, Cheng C, Geng H, Zhong H, Wang J, Lin A, Guttmann D, Soest J, Dekker A, Bilker W, Zhang Z, Rosenthal D, Axelrod R, Galvin J, Frank S, Thorstad W, Huth B, Hsu ..., American Association of Physicists in Medicine Annual Meeting, 1/1/2017
• Evaluation of a Knowledge-Based Atlas for Automated Cardiac Structures Quality Assurance for NCTN Clinical Trial NRG Oncology RTOG 0617 and 1308.
  Hunag M, Guttmann D, Yu J, Cheng C, Geng H, Zhong H, Gore E, Bradley J, Liao Z, Forster K, Gillin M, Mohan R, Xiao Y, American Association of Physicists in Medicine Annual Meeting, 1/1/2017
• Neoadjuvant chemoradiation is associated with improved overall survival in elderly patients with esophageal cancer.
  Guttmann DM, Mitra N, Metz JM, Plastaras J, Feng W, Swisher-McClure S, ASTRO Annual Meeting, 1/1/2017
• Adjuvant Radiation Therapy for Positive Surgical Margins Following Radical Cystectomy for Bladder Cancer: A National Patterns of Care Assessment.
  Venigalla S, Chowdhry A, Guttmann D, Baumann B, Cohen A, Mamtani A, Christodouleas J, ASTRO Annual Meeting, 1/1/2017
• Definitive Local Therapy Improves Overall Survival in Patients with Metastatic Cervical Cancer.
  Venigalla S, Guttmann D, Horne Z, Beriwal S, ASTRO Annual Meeting, 1/1/2017
• Evaluate the Feasibility of Applying Deformable Registration into Adaptive Therapy for NRG Oncology RTOG 1106.
  Zhong H, Guttmann D, Huang M, Geng H, Cheng C, Kong F, Machtay M, Brock K, Xiao Y, ASTRO Annual Meeting, 1/1/2017
• Patterns of failure in metastatic EGFR-mutated non-small cell lung cancer: Implications for the role of definitive local therapy to the primary tumor.
  Guttmann DM, Doucette A, Gabriel P, Morrissette J, Kucharczuk J, Levin W, Simone C, Alley E, Ciunci C, Bauml J, Langer C, Aggarwal C, Cohen R, Evans T Berman AT, Multidisciplinary Thoracic Cancers Symposium, 1/1/2017
• Radiation Dermatitis and Modality Predict Wound Complications In Patients With Soft Tissue Sarcoma.
  LeBrun DG, Guttmann DM, Levin WP, Kovach SJ, Weber KL, Musculoskeletal Tumor Society (MSTS) Annual Meeting, 1/1/2017
• National disparities in treatment 'package time' among patients with surgically-treated head and neck cancers.
  Guttmann DM, Kobie J, Lukens JN, Lin A, Mitra N, Swisher-McClure, S, ASTRO Annual Meeting, 1/1/2016
• Contemporary Forward Planned 3D Radiotherapy: A Wise Choice for Whole Breast Radiation.
  Guttmann DM, Gabriel P, Lin L, Kennedy C, Rate W, Grizos W, Nagda S, Wojtowicz L, Freedman G, ASTRO Annual Meeting, San Antonio, TX, 1/1/2015
• The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women with Early Stage Uterine Carcinosarcoma: A Multi-institutional Study.
  Guttmann DM, Li H, Sevak P, Grover S, Jacobson G, Feldman A, Rubin S, Chu C, Bhatia S, Elshaikh M, Lin L, ASTRO Annual Meeting, San Antonio, TX, 1/1/2015
• Outcomes of Patients with Carcinosarcoma Treated with Combined External Beam Radiation, Brachytherapy, and Chemotherapy.
  Guttmann DM, Li H, Grover S, Bhatia S, Jacobson G, Lin L, ASTRO Annual Meeting, Atlanta, GA, 1/1/2013
• Preclinical studies on the chaperone Hsp27 as a target for radiosensitization in head and neck cancer.
  Guttmann DM, Hart LS, Du K, Koumenis C, ASTRO Annual Meeting, Boston, MA, 1/1/2012
• Hsp27 as a Novel Radiosensitizer in Head and Neck Cancer.
  Guttmann DM, Hart LS, Du K, Koumenis C, National Clinical and Translational Science Predoctoral Programs Meeting, Rochester, MN, 1/1/2012
• Characterization of the phosphorolytic activity that removes beta and gamma phosphates in TriP-RNAs.
  Guttmann DM, Deana A, Belasco JG, Leadership Alliance National Symposium, 1/1/2005
• Join now to see all

Other

• Clinical Outcomes by Disease Site - The Use of Proton Therapy in the Treatment of Cancers of the Central Nervous System. Proton therapy education module 
  Guttmann DM, OncoLink.org
  https://www.oncolink.org/healthcare-professionals/oncolink-university/proton-therapy-professional-education/oncolink-proton-education-modules
  1/8/2015
• Clinical Outcomes by Disease Site - The Use of Proton Therapy in the Treatment of Cancers of the Connective Tissues and Bone. Proton therapy education module 
  Guttmann DM, OncoLink.org
  https://www.oncolink.org/healthcare-professionals/oncolink-university/proton-therapy-professional-education/oncolink-proton-education-modules
  1/8/2015
• Clinical Outcomes by Disease Site - The Use of Proton Therapy in the Treatment of Cancers of the Head and Neck. Proton therapy education module 
  Guttmann DM, OncoLink.org
  https://www.oncolink.org/healthcare-professionals/oncolink-university/proton-therapy-professional-education/oncolink-proton-education-modules
  1/8/2015
• Clinical Outcomes by Disease Site - The Use of Proton Therapy in the Treatment of Cancers of the Lung. Proton therapy education module 
  Guttmann DM, OncoLink.org
  https://www.oncolink.org/healthcare-professionals/oncolink-university/proton-therapy-professional-education/oncolink-proton-education-modules
  1/8/2015
• Join now to see all